Haseltine Lake Kempner LLP: Interpreting Biological Sequence Claims At The EPO – A Cannabinoid Case Study
UK: Interpreting Biological Sequence Claims At The EPO – A Cannabinoid Case Study 20 May 2022 by David Hammond Haseltine Lake Kempner LLP In this next instalment of our series of articles looking at patenting cannabis-related inventions, our focus is on the growth in...
Hogan Lovells: FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products
[co-author: Rachel Buff] Martin Hahn Xin Tao The U.S. Food & Drug Administration (FDA) recently issued Warning Letters to five companies selling products containing delta-8 tetrahydrocannabinol (delta-8 THC) and cannabidiol (CBD). In addition to the various...
BCL Solicitors LLP: David Hardstaff And John Binns Write For Open Access Government Exploring Shifting Sands In The UK CBD Industry
UK: David Hardstaff And John Binns Write For Open Access Government Exploring Shifting Sands In The UK CBD Industry 13 May 2022 by John Binns and David Hardstaff BCL Solicitors LLP UK-based CBD companies may feel they have had a rough ride of late. From operating...
Bradley Arant Boult Cummings LLP: MORE Than Meets the Eye? How Federal Marijuana Legalization Legislation Could Affect Employers
MORE Than Meets the Eye? How Federal Marijuana Legalization Legislation Could Affect Employers Roughly a month ago, the U.S. House of Representative voted to pass the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which decriminalizes marijuana under...
Davis+Gilbert LLP: Cannabis Financing Market Insights
10 May 2022 AUTHOR Joseph Cioffi Davis+Gilbert LLP Davis+Gilbert recently attended the Benzinga Cannabis Capital Conference, where the most significant and influential industry participants met to discuss the opportunities and challenges of funding growth in the...Top 200 Cannabis Lawyers
We Support